Market Tracker

02/27 11:50am ET

ImmunoGen Inc (NASDAQ:IMGN)

7.55
Delayed Data
As of 11:35am ET
 -0.24 / -3.08%
Today’s Change
5.34
Today|||52-Week Range
17.80
+23.77%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close7.79
Today’s open7.83
Day’s range7.55 - 7.89
Volume234,563
Average volume (3 months)1,883,084
Market cap$661.3M
Dividend yield--
Data as of 11:35am ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+4.60%
Earnings growth (this year)+21.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+68.55%
P/E ratioNM
Price/Sales8.71
Price/Book8.72

Competitors

 Today’s
change
Today’s
% change
AERIAerie Pharmaceutical...-0.36-1.28%
FPRXFive Prime Therapeut...-0.83-3.03%
OSIROsiris Therapeutics ...-0.06-0.35%
MNTAMomenta Pharmaceutic...-0.39-2.80%
Data as of 11:46am ET, 02/27/2015

Financials

Next reporting dateApril 24, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$59.9M
Annual profit (last year)-$71.4M
Net profit margin-119.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts